STAB
NASDAQStatera Biopharma Inc.
Latest news
25 items- PRTivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera BiopharmaBroad licensing agreement accelerates Tivic's transformation into a diversified therapeutics company, adds late-stage immunotherapeutic to clinical pipeline. Potential for FDA approval within 24 months. Tivic Health Systems, Inc., (NASDAQ:TIVC) today announced it has acquired worldwide exclusive license rights from Statera Biopharma (OTC:STAB) to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod™ for the treatment of acute radiation syndrome (ARS). In addition, the company has acquired an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta™. This broad licensing agreement establishes Tivic as a diversified t
- PRCRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICAWEST PALM BEACH, Fla., April 11, 2024 /PRNewswire/ -- Anthony, Linder & Cacomanolis, PLLC is proud to announce that Partner Craig D. Linder has been selected to the 2024 Top 50 Lawyers in America list for securities law. This prestigious accolade is part of the 10th annual list honoring a select group of 50 lawyers who have demonstrated outstanding leadership and success within the securities law community in the Americas. America's Top 50 Lawyers identifies and highlights the accomplishments of the nation's most distinguished and skilled attorneys in all fields of practice of law. Only 50 lawyers in each state will receive this honor and be selected for this esteemed membership. This hon
- PRStatera Biopharma Signs Letter of Intent for Merger with Worksite LabsFORT COLLINS, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (OTCPK:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, is pleased to announce it has entered into a non-binding letter of intent (the "LOI") with Worksite Labs, Inc. ("WSL"), setting out the initial proposed terms and conditions pursuant to which the Company and Worksite Labs intend to affect a business combination by a merger structure to be determined involving the Company, one or more merger entities of the Company and WSL (the "Proposed Transaction"). "We believe the proposed merger could e
- SECSEC Form DEFR14A filed by Statera Biopharma Inc.DEFR14A - Statera Biopharma, Inc. (0001318641) (Filer)
- SECSEC Form DEF 14A filed by Statera Biopharma Inc.DEF 14A - Statera Biopharma, Inc. (0001318641) (Filer)
- SECSEC Form PRE 14A filed by Statera Biopharma Inc.PRE 14A - Statera Biopharma, Inc. (0001318641) (Filer)
- SECStatera Biopharma Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Statera Biopharma, Inc. (0001318641) (Filer)
- SECSEC Form 8-A12G filed by Statera Biopharma Inc.8-A12G - Statera Biopharma, Inc. (0001318641) (Filer)
- PRStatera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture MarketplaceFORT COLLINS, CO / ACCESSWIRE / January 24, 2023 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, is pleased to announce it has completed the application process for moving off the OTC Pink Sheets and uplisting to the OTCQB® Venture Marketplace. The application process will not guarantee acceptance of the Company's submission by OTC MARKETS from the PINKS to OTCQB. This is the Company's first step in its pursuit to regain its listing on the NASDAQ exchange.The Company believes that the move to the OTCQB will provide enhanced investor benefits,
- SECStatera Biopharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Statera Biopharma, Inc. (0001318641) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's After-Market SessionGainers Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday's after-market session. The market value of their outstanding shares is at $18.1 million. Benitec Biopharma (NASDAQ:BNTC) stock increased by 11.7% to $0.19. The market value of their outstanding shares is at $5.3 million. AlerisLife (NASDAQ:ALR) stock moved upwards by 9.09% to $0.6. The company's market cap stands at $19.5 million. Renalytix (NASDAQ:RNLX) shares rose 8.55% to $2.03. The company's market cap stands at $76.0 million. electroCore (NASDAQ:ECOR) shares increased by 8.52% to $0.28. The market value of their outstanding shares is at $19.8 million. Statera BioPharma (NASDAQ:STAB) stock increased by 8.37% to $0
- NEWS12 Health Care Stocks Moving In Friday's After-Market SessionGainers Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday's after-market session. The market value of their outstanding shares is at $18.1 million. Benitec Biopharma (NASDAQ:BNTC) stock increased by 11.7% to $0.19. The market value of their outstanding shares is at $5.3 million. AlerisLife (NASDAQ:ALR) stock moved upwards by 9.09% to $0.6. The company's market cap stands at $19.5 million. Renalytix (NASDAQ:RNLX) shares rose 8.55% to $2.03. The company's market cap stands at $76.0 million. electroCore (NASDAQ:ECOR) shares increased by 8.52% to $0.28. The market value of their outstanding shares is at $19.8 million. Statera BioPharma (NASDAQ:STAB) stock increased by 8.37% to $0
- NEWSStocks That Hit 52-Week Lows On FridayFriday's session saw 75 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: Blackstone Mortgage Trust (NYSE:BXMT) was the largest company by market cap to set a new 52-week low. The smallest company by market cap to set a new 52-week low was Mobilicom (NASDAQ:MOB). NanoVibronix (NASDAQ:NAOV) made the largest move down on the session, with shares plummeting 12.14% to reach its 52-week low. Autoscope Technologies (NASDAQ:AATC)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low. The following stocks created new 52-week lows on Friday: Blackstone Mortgage Trust (NYSE:BXMT) shares moved down 1.91% on Friday to hit a new
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Biophytis (NASDAQ:BPTS) stock moved upwards by 95.6% to $0.68 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 1221.7% of its average full-day volume over the last 100 days. The company's market cap stands at $13.9 million. Corbus Pharmaceuticals (NASDAQ:CRBP) shares rose 63.62% to $0.2. As of 12:30 EST, this security is trading at a volume of 88.1 million shares, making up 3330.6% of its average full-day volume over the last 100 days. The company's market cap stands at $24.9 million. Vapotherm (NYSE:VAPO) stock moved upwards by 29.48% to $0.85. Vapotherm's stock is trading at a volume of 789.8K shares as of
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Biophytis (NASDAQ:BPTS) stock moved upwards by 95.6% to $0.68 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 1221.7% of its average full-day volume over the last 100 days. The company's market cap stands at $13.9 million. Corbus Pharmaceuticals (NASDAQ:CRBP) shares rose 63.62% to $0.2. As of 12:30 EST, this security is trading at a volume of 88.1 million shares, making up 3330.6% of its average full-day volume over the last 100 days. The company's market cap stands at $24.9 million. Vapotherm (NYSE:VAPO) stock moved upwards by 29.48% to $0.85. Vapotherm's stock is trading at a volume of 789.8K shares as of
- SECSEC Form DEF 14A filed by Statera Biopharma Inc.DEF 14A - Statera Biopharma, Inc. (0001318641) (Filer)
- NEWSWhy Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From FridayGainers AEye, Inc. (NASDAQ:LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share. EUDA Health Holdings Limited (NASDAQ:EUDA) shares climbed 37% to close at $3.70 on Friday. 8i Acquisition 2 Corp. and EUDA Health Ltd recently completed business combination. Peak Bio, Inc. (NYSE:PKBO) shares surged 36.8% to close at $6.50 on Friday. Kidpik Corp (NASDAQ:PIK) jumped 36.8% to settle at $0.8480. Kidpik recently said Q3 EPS and sales results were down year over year. Expion360 Inc. (NASDAQ:XPON) gained 36.1% to close at $1.47. Expion360 recently posted a Q3 loss of $0.19 per share. Cosmos Holdings Inc. (NASDAQ:COSM) jumped 34.1% to close at
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Peak Bio (NASDAQ:PKBO) stock moved upwards by 34.1% to $6.37 during Friday's regular session. Peak Bio's stock is trading at a volume of 493.5K shares as of 12:30 EST. This is 36.6% of its average full-day volume over the last 100 days. The company's market cap stands at $127.7 million. Cosmos Holdings (NASDAQ:COSM) shares increased by 30.09% to $0.42. As of 12:30 EST, Cosmos Holdings's stock is trading at a volume of 137.1 million, which is 517.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $34.8 million. Cognition Therapeutics (NASDAQ:CGTX) shares increased by 21.76% to $2.35. Trading volume for this security as of 12
- NEWSWhy Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving PremarketGainers VEON Ltd. (NASDAQ:VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion). Cosmos Holdings Inc. (NASDAQ:COSM) rose 26.8% to $0.4058 in pre-market trading. Cosmos Holdings recently posted a Q3 loss of $0.08 per share. JE Cleantech Holdings Limited (NASDAQ:JCSE) rose 22.7% to $0.94 in pre-market trading after jumping around 30% on Wednesday. Statera Biopharma, Inc. (NASDAQ:STAB) rose 15.4% to $0.12 in pre-market trading after gaining more than 6% on Wednesday. Canoo Inc. (NASDAQ:GOEV) rose 13.9% to $1.23 in pre-market trading. Canoo Director, Executive Chairman and CEO Tony A
- SECSEC Form PRE 14A filed by Statera Biopharma Inc.PRE 14A - Statera Biopharma, Inc. (0001318641) (Filer)
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Spruce Biosciences (NASDAQ:SPRB) shares rose 22.9% to $1.29 during Wednesday's regular session. As of 12:30 EST, Spruce Biosciences's stock is trading at a volume of 319.0K, which is 916.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $30.3 million. As per the news, the Q3 earnings report came out 4 days ago. Exagen (NASDAQ:XGN) stock increased by 22.07% to $3.65. As of 12:30 EST, Exagen's stock is trading at a volume of 948.5K, which is 2995.1% of its average full-day volume over the last 100 days. The company's market cap stands at $59.3 million. The company's, Q3 earnings came out 2 days ago. TC BioPharm (Holdings) (N
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers ANI Pharmaceuticals (NASDAQ:ANIP) shares rose 31.1% to $47.99 during Wednesday's pre-market session. The market value of their outstanding shares is at $837.6 million. Sunshine Biopharma (NASDAQ:SBFM) stock increased by 19.48% to $1.0. The company's market cap stands at $22.5 million. Spruce Biosciences (NASDAQ:SPRB) stock increased by 17.14% to $1.23. The company's market cap stands at $28.9 million. As per the news, the Q3 earnings report came out 4 days ago. Statera BioPharma (NASDAQ:STAB) stock increased by 16.86% to $0.14. The company's market cap stands at $7.4 million. Burning Rock Biotech (NASDAQ:BNR) shares increased by 10.52% to $2.52. The market value of their outstan
- NEWS'Statera Biopharma (Formerly Cleveland Biolabs) Has Been Granted European Patent Number Ep3206708 Titled "Methods And Compositions For The Treatment Of Radiation-related Disorders"' - EPOMETHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS - European Patent Office - EP 3206708 B1 (epo.org)
- SECStatera Biopharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Statera Biopharma, Inc. (0001318641) (Filer)
- SECSEC Form 10-Q filed by Statera Biopharma Inc.10-Q - Statera Biopharma, Inc. (0001318641) (Filer)
STAB FAQ
6 questionsWhat does Statera Biopharma Inc. do?
Cytocom, Inc., a clinical-stage biopharmaceutical company, develops novel small molecule immunotherapies targeting cancer, autoimmune, inflammatory, and infectious diseases. Its platform, Advanced Immunomodulating Multi-receptor System (AIMS), offers noroxymorphone analogs multi-receptor modulating therapies and proenkephalin analogs multi-receptor modulating therapies. The company also has various clinical-stage development programs, including CYTO-200 for Crohn's disease, fibromyalgia, multiple sclerosis, and covid-19; CYTO-400 for hepatocellular and pancreatic cancer; and CYTO-600 for...Where does STAB stock trade?
Statera Biopharma Inc. (STAB) is listed on NASDAQ.What sector and industry is STAB in?
Statera Biopharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Statera Biopharma Inc. go public?
Statera Biopharma Inc. (STAB) completed its IPO in 2006.What companies are similar to STAB?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare STAB side-by-side with any of them on Quantisnow.How can I track STAB on Quantisnow?
Quantisnow aggregates Statera Biopharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow STAB to receive live email and push alerts on every new disclosure.